Investor · BECKENHAM, United Kingdom

Christopher A. Day

Open Christopher in the network graph →

Filings

9

SEC Form D

Connections

43

co-filers

Capital

$211.4M

across filings

Active

Jun 2019

to May 2023

Most-connected co-filers (43)

Stacey-Ann Kirkconnell · Singapore, U08 shared Tomofumi Oda · SINGAPORE, U06 shared Colin Siew · SINGAPORE, U05 shared Gregory Parrish · Charleston, SC4 shared Philip A. Daian · GRAND CAYMAN, Cayman Islands4 shared Rizwan Nusrat · Vienna, VA4 shared Mariam Nusrat · Vienna, VA4 shared Kerstin Dittmar · San Francisco, CA4 shared Jonathan Booth · Baton Rouge, LA4 shared Marcy Venture Partners Gp, Llc · San Francisco, CA3 shared Vertical Capital, LLC · New York, NY3 shared Alison Simpson · George Town, Grand Cayman, Cayman Islands3 shared Craig T. Theirl · New York, NY3 shared John Vincent · New York, NY3 shared Matthew Miller · Vienna, VA3 shared Aviram T. Wertheim · Ramat Gan, L32 shared Lani Baker · Tucson, AZ2 shared Christopher M. Santana · New York, NY2 shared Michael Augins · Scottsdale, AZ2 shared Marcy Venture Partners Gp, Llc · San Francisco, CA2 shared Elona Baum · South San Francisco, CA2 shared Benjamin Carter · South San Francisco, CA2 shared Stephen Thau · South San Francisco, CA2 shared Catherine Sohn · South San Francisco, CA2 shared

Recent filings (9)

BLUE SWELL JAPAN MARKET NEUTRAL FUNDMay 2023 · 11 co-filers BLUE SWELL JAPAN MARKET NEUTRAL FUNDAug 2022 · 11 co-filers BLUE SWELL JAPAN MARKET NEUTRAL FUNDAug 2021 · 10 co-filers MVP Culture Opportunity Fund II, L.P.Feb 2021 · 10 co-filers$11.6M BLUE SWELL JAPAN MARKET NEUTRAL FUNDSep 2020 · 11 co-filers BioEclipse Therapeutics, Inc.Oct 2019 · 22 co-filers$11.8M MVP Culture Opportunity Fund, L.P.Jul 2019 · 6 co-filers$12.1M MVP Travel Opportunity Fund, L.P.Jun 2019 · 10 co-filers$2.1M BioEclipse Therapeutics, Inc.Jun 2019 · 22 co-filers$9.1M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Christopher in the interactive graph →